Citation Impact
Citing Papers
Microbiota in health and diseases
2022 Standout
Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice
2015
Delivering safer immunotherapies for cancer
2017
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
2012
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Hypomorphic Mutation in the Site-1 Protease Mbtps1 Endows Resistance to Persistent Viral Infection in a Cell-Specific Manner
2011 StandoutNobel
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
2011
Macrophages in immunoregulation and therapeutics
2023 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
2013
Oncolytic viruses: a novel form of immunotherapy
2008
Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
2011
Oncolytic viruses: a new class of immunotherapy drugs
2015
Delivery technologies for cancer immunotherapy
2019 Standout
The evolving role of dendritic cells in cancer therapy
2010
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
2015
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
2020
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Molecular evolution of the MAGUK family in metazoan genomes
2007
Going viral with cancer immunotherapy
2014
Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse
2013
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
2012
Oncolytic virotherapy
2012
Measles virus causes immunogenic cell death in human melanoma
2011
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
2009
Management of glioblastoma: State of the art and future directions
2020 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Evolution of CASK into a Mg 2+ -Sensitive Kinase
2010 StandoutNobel
Evolution of Oncolytic Viruses: Novel Strategies for Cancer Treatment
2013
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M-CSF-Differentiated Bone Marrow-Derived Cells
2019
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Candice Willmon being referenced
Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy
2009
A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing
2006
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
2007
Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors
2008
Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus
2014
Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide
2010
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer
2008
Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2
2009
Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
2009